Loading clinical trials...
Loading clinical trials...
The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were assessed with the use of an implanted monitoring device (IMD).
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
University of Rochester
Rochester, New York, United States
State Research Institute of Circulation Pathology
Novosibirsk, Russia
Start Date
June 1, 2013
Primary Completion Date
December 1, 2015
Completion Date
February 1, 2016
Last Updated
September 23, 2015
60
ESTIMATED participants
radiofrequency ablation
PROCEDURE
botulinum toxin injection
DRUG
Lead Sponsor
Meshalkin Research Institute of Pathology of Circulation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions